clinical trial · NCT04875806
A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors
Advanced or Metastatic Solid TumorsOvarian CancerNon-small Cell Lung CancerBreast CancerNC762
brief summary
This research study is studying a new drug, NC762, as a possible treatment for advanced or metastatic solid tumors.
started
Jun 30, 2021
primary completion
Jan 30, 2024
completion
Jan 30, 2024
last updated
Apr 22, 2025
official title
A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol